Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.315
+0.005 (0.22%)
At close: Jun 27, 2025, 4:00 PM
2.310
-0.005 (-0.22%)
After-hours: Jun 27, 2025, 5:12 PM EDT
Autolus Therapeutics Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Autolus Therapeutics stock ranges from a low of $6.00 to a high of $13. The average analyst price target of $9.32 forecasts a 302.59% increase in the stock price over the next year.
Price Target: $9.32 (+302.59%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +331.97% | Jun 12, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +331.97% | Apr 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +331.97% | Apr 1, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +159.18% | Mar 21, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +331.97% | Jan 13, 2025 |
Financial Forecast
Revenue This Year
56.85M
from 10.12M
Increased by 461.76%
Revenue Next Year
120.90M
from 56.85M
Increased by 112.66%
EPS This Year
-0.93
from -0.86
EPS Next Year
-0.81
from -0.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 81.9M | 168.7M | 473.6M | ||
| Avg | 56.9M | 120.9M | 257.4M | ||
| Low | 37.8M | 89.7M | 110.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 708.9% | 196.7% | 291.7% | ||
| Avg | 461.8% | 112.7% | 112.9% | ||
| Low | 273.2% | 57.7% | -8.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.55 | -0.37 | -0.17 | ||
| Avg | -0.93 | -0.81 | -0.57 | ||
| Low | -1.23 | -1.16 | -1.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.